Economic and social cost of epilepsy in Poland: 5-year analysis

Business & Economics

• Absenteeism 19%
• Burden 11%
• Chronic Disease 17%
• Cost Drivers 17%
• Costs 25%
• Decision Maker 8%
• Drugs 10%
• Economic Cost 86%
• Epilepsy 87%
• Expenditure 9%
• Expenses 10%
• Health Care System 12%
• Hospitalization 32%
• Human Capital 9%
• Indirect Costs 97%
• Outpatient 14%
• Patient with Epilepsy 55%
• Poland 69%
• Productivity 7%
• Public Institutions 15%
• Rehabilitation 12%
• Resources 8%
• Social Costs 83%
• Time Trends 16%
• Top-down Approach 16%

Social Sciences

• absenteeism 7%
• Chronic Diseases 7%
• costs 44%
• decision maker 5%
• driver 5%
• drug 4%
• economics 33%
• epilepsy 100%
• expenditures 5%
• Healthcare 5%
• human capital 6%
• Poland 72%
• productivity 5%
• public institution 6%
• rehabilitation 5%
• resources 2%
• social costs 91%
• time 2%
• trend 3%

Medicine & Life Sciences

• Absenteeism 8%
• Ambulatory Care 6%
• Chronic Disease 4%
• Costs and Cost Analysis 49%
• Delivery of Health Care 4%
• Drug Costs 8%
• Drug Therapy 3%
• Economics 61%
• Efficiency 7%
• Epilepsy 67%
• Health Expenditures 6%
• Hospitalization 9%
• International Classification of Diseases 13%
• Poland 88%
• Rehabilitation 5%
• Sick Leave 8%